Arcturus Therapeutics Holdings Inc. (ARCT) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-15

Arcturus Therapeutics Holdings Inc. (ARCT) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-15. 3 Form 8-K material event filings were reported by ARCT in the last 90 days. InsiderAlpha tracks every ARCT SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Arcturus Therapeutics Holdings Inc. (ARCT)

SEC CIK	0001768224

90-Day SEC Filing Activity

Form 4 filings (90d)	8
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-06-15

Recent ARCT Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-08-15	SASSINE ANDY	Chief Financial Officer	P — Open-market purchase	1.2K	$16.56	$20K	SEC
2024-10-15	Chivukula Pad	Chief Scientific Officer & COO	S — Open-market sale [10b5-1]	12.0K	$20.76	$249K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Arcturus Therapeutics Holdings Inc. (ARCT). Updated in real time as new filings are submitted to the SEC.

Most-Active ARCT Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
FARRELL PETER C	1	—
Markels John	1	—
BARLOW JAMES F	1	—
HOLMES EDWARD W	1	—
Marantz Jing L.	1	—

Recent ARCT Form 8-K Material Events

2026-07-02 — Item 1.01, 7.01, 9.01 [SEC]
2026-06-05 — Item 5.07 [SEC]
2026-05-07 — Item 2.02, 5.02, 7.01, 9.01 [SEC]
2026-03-03 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Arcturus Therapeutics announced financial results for Q4 2025 and full year 2025, along with a corporate update on pipeline programs including ARCT-032 and ARCT-810. The filing provides standard quarterly and annual financial reporting without explicit beat/miss language or mater

Recent Insider Filings

2026-06-15 — HOLMES EDWARD W (Director)
2026-06-15 — FARRELL PETER C (Director)
2026-06-15 — BARLOW JAMES F (Director)
2026-06-15 — Markels John (Director)
2026-06-15 — Slaoui Moncef (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ARCT insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ARCT Insider Trading — FAQ

What is the latest insider trade for ARCT?: Arcturus Therapeutics Holdings Inc. (ARCT) had 8 insider filings in the last 90 days, with the most recent on 2026-06-15. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ARCT stock?: 0 insider purchases of ARCT were filed in the last 90 days.
How many insiders are selling ARCT stock?: 0 insider sales of ARCT were filed in the last 90 days.
Where can I see ARCT SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ARCT SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live ARCT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.